Drug Sensitivity and Resistance Testing Platform for Personalized Medicine at the Institute for Molecular Medicine Finland (FIMM)Wednesday, 18 February 2015 at 09:00 Add to Calendar ▼2015-02-18 09:00:002015-02-18 10:00:00Europe/LondonDrug Sensitivity and Resistance Testing Platform for Personalized Medicine at the Institute for Molecular Medicine Finland (FIMM)Screening Europe in Berlin, GermanyBerlin, GermanySELECTBIOenquiries@selectbiosciences.com At FIMM, a drug sensitivity and resistance platform is used for ex vivo drug testing of primary cancer cells as well as cancer cell lines. Application of the platform to AML patient samples has uncovered taxonomic drug-response subtypes and individualised therapy based on DSRT has resulted in several clinical responses. |